DUSP22 and cancer: LUSC1 enriched for alterations in DUSP22, KSR2, ATXN2 and RAD50 and LUSC2 enriched for KEAP1. The enrichment of these cancer driver alterations in proteotypes might explain some of the differences seen at the proteome level.